oasis 1 trial oral semaglutide 50 mg obesity nejm 2023 Frontiers Semaglutide in Patients with Obesity-Related

Real-world outcomes from clinical practices align closely with these trial results, though individual variation remains significant

Drucker provides this illustration of the mechanism: Scientists still arent quite sure how these drugs effectively moderate every system that they touch

Studies on bariatric surgery patients show anxiety scores decline significantly following substantial weight reduction, suggesting that the mechanical act of losing weight carries independent mental health benefits beyond any direct drug effect

The Wayne State / Brooklyn College work does not build on those in vivo results directly, but the two papers together suggest the transdermal route is reproducibly reaching the tissue layer that matters, at least in preclinical conditions